Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100051785Phase 4Not yet recruiting
Phase 4, randomised trial in supine hypotensive syndrome (SHS) and hypotension comparing Phenylephrine group, Norepinephrine group and Metaraminol group (3 arms). Primary endpoint: Umbilical artery blood pH. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100051785.